---
title: "Sumitomo Chemical Company: Q1 FY2026 saw a sharp profit recovery and strong sales growth across most business segments"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294768787.md"
description: "Sales and profits rebounded strongly in Q1 FY2026, with net income turning positive and all major segments except ICT & Mobility Solutions and Sumitomo Pharma showing improved core operating income. Full-year guidance remains unchanged, with a stable dividend outlook.Original document: Sumitomo Chemical Co., Ltd. [4005] Interim report — Aug. 4 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-04T04:32:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294768787.md)
  - [en](https://longbridge.com/en/news/294768787.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294768787.md)
generator: "portal-rs"
---

# Sumitomo Chemical Company: Q1 FY2026 saw a sharp profit recovery and strong sales growth across most business segments

Sales and profits rebounded strongly in Q1 FY2026, with net income turning positive and all major segments except ICT & Mobility Solutions and Sumitomo Pharma showing improved core operating income. Full-year guidance remains unchanged, with a stable dividend outlook.

Original document: Sumitomo Chemical Co., Ltd. \[4005\] Interim report — Aug. 4 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [4005.JP](https://longbridge.com/en/quote/4005.JP.md)
- [4506.JP](https://longbridge.com/en/quote/4506.JP.md)

## Related News & Research

- [Sumitomo Chemical buys COPYR plant protection unit Pyragro](https://longbridge.com/en/news/294897621.md)
- [Sumitomo Pharma Profit Jumps on U.S. Asset Transfer and Asian Stake Sale](https://longbridge.com/en/news/286196456.md)
- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)
- [Does Sumitomo Warehouse’s Q1 Beat And Steady Dividend Outlook Shift The Bull Case For TSE:9303?](https://longbridge.com/en/news/296646936.md)
- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**